We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$301M
AUM Growth
+$14.9M
Cap. Flow
-$4.44M
Cap. Flow %
-1.47%
Top 10 Hldgs %
70.91%
Holding
39
New
2
Increased
2
Reduced
3
Closed

Top Buys

Rank Stock Value
1
BG icon
Bunge Global
BG
+$4.68M
2
ADM icon
Archer Daniels Midland
ADM
+$2.94M
3
VICR icon
Vicor
VICR
+$583K
4
DAR icon
Darling Ingredients
DAR
+$440K

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$5.71M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$2.77M
3
KOD icon
Kodiak Sciences
KOD
+$245K

Sector Composition

Rank Sector Weight
1 Healthcare 34.19%
2 Utilities 24.87%
3 Industrials 16.85%
4 Financials 7.4%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL.B icon
1
U-Haul Holding Co Series N
UHAL.B
$12.2B
$32.9M 10.91%
493,350
-43,000
-8% -$2.77M
MRK icon
2
Merck
MRK
$315B
$29.1M 9.66%
220,700
ABBV icon
3
AbbVie
ABBV
$450B
$25.1M 8.34%
138,000
ALL icon
4
Allstate
ALL
$64.3B
$22M 7.3%
127,200
DUK icon
5
Duke Energy
DUK
$97.5B
$19.7M 6.54%
203,890
CMS icon
6
CMS Energy
CMS
$22.8B
$19.1M 6.32%
316,000
NEE icon
7
NextEra Energy
NEE
$185B
$18.8M 6.22%
293,600
ABT icon
8
Abbott
ABT
$175B
$17M 5.65%
150,000
T icon
9
AT&T
T
$152B
$16.9M 5.61%
961,000
IIIN icon
10
Insteel Industries
IIIN
$602M
$13.1M 4.35%
343,423
XEL icon
11
Xcel Energy
XEL
$49.2B
$10.4M 3.44%
193,000
-100,000
-34% -$5.71M
PFE icon
12
Pfizer
PFE
$143B
$7.45M 2.47%
268,500
AVA icon
13
Avista
AVA
$3.45B
$7.06M 2.34%
201,500
DAR icon
14
Darling Ingredients
DAR
$10B
$6.98M 2.31%
150,000
+10,000
+7% +$440K
BHC icon
15
Bausch Health
BHC
$1.8B
$6.83M 2.27%
644,000
AAPL icon
16
Apple
AAPL
$4.9T
$6.02M 2%
35,100
BG icon
17
Bunge Global
BG
$23.1B
$5.13M 1.7%
+50,000
New +$4.68M
UHAL icon
18
U-Haul Holding Co
UHAL
$13.9B
$4.78M 1.59%
70,805
FOCL
19
EDAP TMS S.A.
FOCL
$204M
$4.07M 1.35%
553,652
ADM icon
20
Archer Daniels Midland
ADM
$41.4B
$3.14M 1.04%
+50,000
New +$2.94M
SUPN icon
21
Supernus Pharmaceuticals
SUPN
$2.79B
$2.8M 0.93%
82,105
LVTX
22
DELISTED
LAVA Therapeutics
LVTX
$2.57M 0.85%
771,874
NEM icon
23
Newmont
NEM
$95.8B
$2.35M 0.78%
65,600
KOD icon
24
Kodiak Sciences
KOD
$2.67B
$2.22M 0.74%
423,000
-50,000
-11% -$245K
SIRI icon
25
SiriusXM
SIRI
$10.3B
$2.16M 0.72%
55,784

Similar funds

Bruce & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Bruce & Co held 39 positions worth $301M, up 5.2% from $287M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bruce & Co's Q1 2024 filing shows 2 new, 2 increased and 3 reduced positions. Its largest new stake was Bunge Global: 50,000 shares worth $5.13M. The largest sale was Xcel Energy, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co's largest Q1 2024 buy was Bunge Global: 50,000 shares worth $5.13M.
  • Bruce & Co added most to Vicor in Q1 2024, an estimated $583K increase.
  • Bruce & Co's biggest Q1 2024 reduction was Xcel Energy, cutting an estimated $5.71M.
  • Bruce & Co's ten largest holdings make up 71% of its $301M portfolio in Q1 2024.
  • Bruce & Co opened 2 new positions and closed 0 in Q1 2024.
  • Bruce & Co's portfolio value rose 5.2% quarter-over-quarter to $301M.

Based on Bruce & Co's 13F filing for Q1 2024, filed 13 May 2024.